Last week, an FDA advisory committee met to discuss the benefits and risks of flibanserin, a drug intended to restore a woman's sexual desire. The panel voted 18-6 that the FDA approve the drug with ...

The U.S. Food and Drug Administration has once again raised concerns about the safety of flibanserin, an experimental women's libido drug, saying it increased the risk of fainting and accidental ...

After three applications, ownership by two drug companies, and one successful lobbying campaign, the female sexual-dysfunction drug flibanserin was approved yesterday by the Food and Drug ...

I’m a 37-year-old married female with two small children, a full-time job, and not enough hours in the day. Putting my career as a journalist aside, you’re darn straight I have a lot of questions ...

Todd Lodwick celebrates his first place finish in the 10K to secure a place on the United States Olympic team for Sochi 2014 during the Nordic Combined Olympic Trial Dec. 28, 2013 in Park City, Utah.

For women with hypoactive sexual desire disorder, flibanserin (Addyi) can improve both sexual and nonsexual symptoms, report researchers at the Sexual Medicine Society of North America Fall 2016 ...

Update 4:40 p.m.: The panel of advisers to the Food and Drug Administration voted 18 to 6 to recommend that the agency approve flibanserin, as long as there are measures in place to make sure that ...